Insulin-like Growth Factor I and Urokinase-type Plasminogen Activator Bioregulation System as a Survival Mechanism of Prostate Cancer Cells in Osteoblastic Metastases: Development of Anti-Survival Factor Therapy for Hormone-Refractory Prostate Cancer

This publication has 107 references indexed in Scilit:

• Enhanced Invasion and Liver Colonization by Lung Carcinoma Cells Overexpressing the Type 1 Insulin-Like Growth Factor Receptor
  Experimental Cell Research, 1998
• Insulin-like Growth Factor 1 Inhibits Apoptosis Using the Phosphatidylinositol 3′-Kinase and Mitogen-activated Protein Kinase Pathways
  Journal of Biological Chemistry, 1997
• Mutation of the Androgen-Receptor Gene in Metastatic Androgen-Independent Prostate Cancer
  New England Journal of Medicine, 1995
• Mediation of glucocorticoid receptor function by transforming growth factor beta I expression in human PC‐3 prostate cancer cells
  The Prostate, 1995
• Androgen receptors in endocrine‐therapy‐resistant human prostate cancer
  International Journal of Cancer, 1991
• An amino-terminal fragment of urokinase isolated from a prostate cancer cell line (PC-3) is mitogenic for osteoblast-like cells
  Biochemical and Biophysical Research Communications, 1990
• A mutation in the ligand binding domain of the androgen receptor of human INCaP cells affects steroid binding characteristics and response to anti-androgens
  Biochemical and Biophysical Research Communications, 1990
• A Controlled Trial of Leuprolide with and without Flutamide in Prostatic Carcinoma
  New England Journal of Medicine, 1989
• Anti‐hormone Treatment for Prostate Cancer Relapsing after Treatment with Flutamide and Castration
  British Journal of Urology, 1989
• Androgen depletion and repletion as a means of potentiating the effect of cytotoxic chemotherapy in advanced prostate cancer
  Journal of Steroid Biochemistry, 1987